Replimune Group, Inc. (REPL)
2.17
-0.02
(-0.91%)
USD |
NASDAQ |
Apr 17, 16:00
2.12
-0.05
(-2.30%)
After-Hours: 06:49
Replimune Group SG&A Expense (Quarterly) : 18.73M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 82.79M |
| Bristol Myers Squibb Co. | 2.181B |
| Phathom Pharmaceuticals, Inc. | 48.37M |
| REGENXBIO, Inc. | 22.38M |
| Catalyst Pharmaceuticals, Inc. | 48.23M |